Pharmaceutical Manufacturing of Bismuth Subsalicylate Tablets

The contract involves the pharmaceutical manufacturing of Bismuth Subsalicylate tablets under strict adherence to FDA current Good Manufacturing Practices, ensuring product safety, efficacy, and consistency throughout formulation, compression, and quality control processes. All production must comply with MIL-STD-129 labeling requirements and ASTM D3951 packaging standards, guaranteeing that each unit is properly marked, packaged, and prepared for military distribution. The work is to be performed by a subcontractor supporting the Department of Defense through the Medical Supply Chain Pharm FSA, with the place of performance designated as FPO, ZIP 96632. The solicitation was posted on August 2, 2026, and responses are due by August 10, 2026, under NAICS code 325412 for pharmaceutical preparation manufacturing. All deliverables must meet federal and military specifications without exception, with no set-aside provisions indicated for small or disadvantaged businesses.